Your session is about to expire
← Back to Search
Microvessel Ultrasound Imaging for Chronic Ulcers
N/A
Recruiting
Led By Michael Moynagh, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Chronic wound in the course of diabetic foot ulcers and/or lower extremity venous ulcers with duration of at least 6 weeks and the wound surface not less than 2 sq. cm and not greater than 15 sq. cm, without evidence of active infection of the wound at the time of qualification to participate in the study
Meets criteria for stalled chronic wound defined as less than 50% reduction in wound size after 30 days of standard of care management
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial uses ultrasounds to look for scarring and monitor wound healing, to see if treatments improve circulation.
Who is the study for?
This trial is for people with chronic ulcers on their lower extremities that have not healed in at least 6 weeks and are between 2-15 sq. cm in size. Participants must have controlled blood sugar, adequate blood flow to the wound, and no active infections or allergies to lidocaine. Smokers and pregnant individuals cannot participate.Check my eligibility
What is being tested?
The study tests a high-resolution microvessel ultrasound imaging system's ability to detect scarring and monitor healing in chronic wounds. It also examines how treatments affect tiny blood vessels and circulation around the wound.See study design
What are the potential side effects?
Potential side effects may include discomfort or minor pain from the ultrasound examination or skin biopsy procedure, as well as possible bruising or bleeding at the biopsy site.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a long-lasting wound from diabetes or poor leg circulation that's between 2 and 15 sq. cm large, without any signs of infection.
Select...
My wound has not shrunk by half after 30 days of standard treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Microvessel imaging
Trial Design
1Treatment groups
Experimental Treatment
Group I: Microvessel Ultrasound Imaging for Chronic UlcersExperimental Treatment2 Interventions
Subjects with chronic diabetic ulcers and venous ulcers will undergo wound debridement and treatment as standard of care and receive research microvessel ultrasound examination and two skin biopsies
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Skin Biopsy
2015
Completed Phase 4
~680
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,478 Total Patients Enrolled
Michael Moynagh, MDPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are allergic to lidocaine.I have a long-lasting wound from diabetes or poor leg circulation that's between 2 and 15 sq. cm large, without any signs of infection.My diabetic foot wound has a poor blood supply, confirmed by a TCPO2 test.My foot wound has a good blood supply, confirmed by a TCPO2 test.My limb's blood flow improved after a procedure, confirmed by ultrasound.You are a person who smokes cigarettes.My wound is newer than 6 weeks.My wound has not shrunk by half after 30 days of standard treatment.I am currently fighting an infection or taking antibiotics.
Research Study Groups:
This trial has the following groups:- Group 1: Microvessel Ultrasound Imaging for Chronic Ulcers
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining positions available for this research endeavor?
"The trial posted on March 1st 2023 is no longer recruiting patients, as per the latest data available on clinicaltrials.gov from February 13th 2023. Nevertheless, 1072 alternative studies are currently looking for participants at this time."
Answered by AI
Share this study with friends
Copy Link
Messenger